Clinical Challenges in Genitourinary Cancers

EP. 1: Treatment of Bone Metastases in Prostate Cancer

June 1st 2016

EP. 2: Defining Symptomatic in Prostate Cancer

June 1st 2016

EP. 3: Factors Impacting Treatment Approach in Advanced Prostate Cancer

June 1st 2016

EP. 4: Combining Radium-223 With Other Therapies in Prostate Cancer

June 1st 2016

EP. 5: Local and Systemic Therapeutic Options in Low-Volume Prostate Cancer

June 1st 2016

EP. 6: Candidacy for Chemotherapy in Oligometastatic Prostate Cancer

June 1st 2016

EP. 7: Potential Predictive Markers in Prostate Cancer

June 1st 2016

EP. 8: Safety of Low-Dose Steroids with Abiraterone in Prostate Cancer

June 1st 2016

EP. 9: Therapeutic Options in Metastatic CRPC

June 1st 2016

EP. 10: CRPC: Patient Selection in AR-Directed Therapies

June 1st 2016

EP. 11: Abiraterone Plus Prednisone in CRPC: Factors to Consider

June 1st 2016

EP. 12: First-Line Options in Muscle-Invasive Bladder Cancer

June 1st 2016

EP. 13: Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer

June 1st 2016

EP. 14: Check Point Inhibition in Muscle-Invasive Bladder Cancer

June 1st 2016

EP. 15: Approaches in High-Risk Non-Muscle Invasive Bladder Cancer

June 1st 2016

EP. 16: Measuring Response in Non-Muscle Invasive Bladder Cancer

June 1st 2016

EP. 17: The Role of Biomarkers in Bladder Cancer

June 1st 2016

EP. 18: A Look Ahead in Genitourinary Cancers

June 1st 2016